Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

February 4, 2022

Study Completion Date

February 4, 2022

Conditions
Healthy Subjects
Interventions
DRUG

MT-7117

MT-7117

Trial Locations (2)

33147

Advanced Pharma CR, LLC, Miami

78217

Worldwide Clinical Trials, San Antonio

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY